IQGAP1 is of particular interest as a therapeutic target because it serves as a node for many signalling pathways implicated in cancer progression (Hedman et al., 2015; Johnson et al., 2009; Smith et al., 2015; White et al., 2009). This evidence concerns the gene IQGAP1 and cancer.